BioCentury
ARTICLE | Clinical News

Azzalure abobotulinumtoxinA regulatory update

July 6, 2009 7:00 AM UTC

Ipsen and Galderma said Azzalure abobotulinumtoxinA was approved in Germany to treat moderate to severe glabellar lines (frown lines between the eyebrows) for aesthetic applications. Galderma plans to...